Drug Trial Radar · NCT02983227
A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350
Last checked: Nov 19, 2026Latest source record: Aug 3, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
496
Actual
Start
Nov 30, 2016
Primary completion
Jul 17, 2019
Study completion Jul 17, 2019
Sponsor
- Lead sponsor
- Genentech, Inc.Roche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Dec 6, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 76 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study to evaluate the long-term safety and efficacy of GDC-0853 in participants with moderate to severe active Rheumatoid Arthritis (RA) who have completed 12 weeks of study treatment in Study GA29350. Eligible participants from Study GA29350 who elect to participate will receive treatment with GDC-0853 twice daily (BID) in an open-label fashion for 52 weeks, followed by a safety follow-up period of 8 weeks.
Conditions
- Rheumatoid Arthritis
Interventions
GDC-0853Drug
GDC-0853 was administered orally at a dose of 200mg, as per the dosing schedules described above.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Adverse Events (AEs)Time frame: Day 1 up until 8 weeks after the last dose of study drug (up to 1 year, 2 months)
- Percentage of Participants Achieving American College of Rheumatology 50% (ACR50) Response at Week 52Time frame: Week 52
Locations
104 sites in 10 countries. Site status is shown where the registry gives one.
Arizona Arthritis & Rheumatology Associates, P.C.
Glendale, Arizona
Medvin Clinical Research
Covina, California
TriWest Research Associates, LLC
El Cajon, California
Saint Jude Heritage Medical Grp
Fullerton, California
RASF-Clinical Research Center
Boca Raton, Florida
Clinical Research of West Florida
Clearwater, Florida
Medication Management
Greensboro, North Carolina
Oregon Health & Science Uni
Portland, Oregon
Metroplex Clinical Research Centre
Dallas, Texas
Baylor Research Inst.
Dallas, Texas
Accurate Clinical Research
Houston, Texas
Instituto de Investigaciones Clinicas-Mar del Plata
Buenos Aires, Argentina
APRILLUS
Buenos Aires, Argentina
Instituto centenario
Buenos Aires, Argentina
Centro de Investigacion en Enfermedades Reumaticas CIER
Ciudad Autonoma Buenos Aires, Argentina
Expertia S.A- Mautalen Salud e Investigación
Ciudad Autonoma Buenos Aires, Argentina
CCBR - Buenos Aires - AR; AxisMed SRL
Ciudad Autonoma Buenos Aires, Argentina
ILAIM-CEOM Inst. Latinoamericano de Inv. Medicas
Córdoba, Argentina
Centro de Investigaciones Medicas Mar Del Plata
Mar del Plata, Argentina
Instituto de Investigaciones Clinicas
Rosario, Argentina
CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica
San Juan, Argentina
Centro Medico Privado de Reumatologia; Reumathology
San Miguel, Argentina
CIP - Centro Internacional de Pesquisa X; Pesquisa Clinica
Goiânia, Goiás, Brazil
CMiP - Centro Mineiro de Pesquisa*X*
Juiz de Fora, Minas Gerais, Brazil
Centro de Estudos em Terapias Inovadoras - CETI
Curtiba, Paraná, Brazil
CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda.
Rio de Janeiro, Rio de Janeiro, Brazil
LMK Serviços Médicos S/S
Porto Alegre, Rio Grande do Sul, Brazil
CAEP - Centro Avancado de Estudos e Pesquisas Ltda.
Campinas, São Paulo, Brazil
IMA Brasil - Instituto de Medicina Avancada
São Paulo, São Paulo, Brazil
MHAT "Eurohospital" - Plovdiv, OOD; Internal Department
Plovdiv, Bulgaria
UMHAT "Kaspela", EOOD
Plovdiv, Bulgaria
Medizinski Zentrar-1-Sevlievo EOOD
Sevlievo, Bulgaria
MHAT "Hadzhi Dimitar", OOD
Sliven, Bulgaria
Medical Center Excelsior OOD
Sofia, Bulgaria
NMTH "Tsar Boris III"
Sofia, Bulgaria
DCC "Alexandrovska", EOOD; Clinic of Neurology
Sofia, Bulgaria
MC "Synexus - Sofia", EOOD
Sofia, Bulgaria
UMHAT "SofiaMed", OOD; Department of Neurology
Sofia, Bulgaria
Centro de Investigacion Medico Asistencial S.A.S
Barranquilla, Colombia
Centro de Investigacion en Reumatologia y Especialdades Medicas SAS. CIREEM
Bogotá, Colombia
Showing 40 of 104 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.